Natural autoantibodies and anti-idiotypes

Seminars in Thrombosis and Hemostasis

Volumn 26, Issue 2, 2000, Pages 151-155

  Gilles, Jean Guy G ^a   Vanzieleghem, Beatrüs ^a   Saint Remy, Jean Marie R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Anti factor VIII; Anti idiotypes; Antibodies; Autoantibodies; Factor VIII; Hemophilia A

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; AUTOANTIBODY; BLOOD CLOTTING FACTOR 8 ANTIBODY; NEUTRALIZING ANTIBODY; BLOOD CLOTTING FACTOR 8;

AUTOIMMUNITY; DESENSITIZATION; HEMOPHILIA A; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; PRIORITY JOURNAL; REVIEW; ANIMAL; AUTOIMMUNE DISEASE; CHEMISTRY; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FACTOR VIII; HEMOPHILIA A; HUMANS; IMMUNE TOLERANCE;

EID: 0033921481     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. 1. Kearney JF, Vakil M. Idiotype-directed interactions during ontogeny play a major role in the establishment of the adult B cell repertoire. Immunol Rev 1986;94:39-50
2. 2. Durandy A, Thuillier L, Forveille M, Fischer A. Phenotypic and functional characteristics of human newborns' B lymphocytes. J Immunol 1990;144:60-65
3. 3. Nakamura M, Burastero SE, Ueki Y, et al. Probing the natural and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus. J Immunol 1988;141:4165-4172
4. 4. Casali P, Notkins AL. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 1989;10:364-368
5. 5. Kasaian M, Ikematsu H, Casali P. Identification and analysis of a novel human surface. CD5-B lymphocyte subset producing natural antibodies. J Immunol 1992;148:2690-2702
6. 6. Lacroix-Desmazes S, Kaveri S, Mouthon L, et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods 1998;216:117-137
7. 7. Avrameas S. Natural autoantibodies: From "horror autotoxicus" to "gnothi seauton." Immunol Today 1991;12:154-159
8. 8. Lutz HU, Wipf G. Naturally occurring autoantibodies to skeletal proteins from human red blood cells. J Immunol 1982;128: 1695-1699
9. 9. Galili U, Basbaum C, Shohet S, Buehler J, Macher B. Identification of erythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13. J Biol Chem 1987;262: 4683-4688
10. 10. Elson C, Naysmith, J, Taylor R. B-cell tolerance and autoimmunity. Int Rev Exp Pathol 1979;19:137-203
11. 11. Rossi F, Guilbert B, Tonnelle C, et al. Idiotypic interactions between normal human polyspecific IgG and natural IgM antibodies. Eur J Immunol 1990;20:2089-2094
12. 12. Ternynck T, Avrameas S. Murine natural monoclonal autoantibodies: A study of their polyspecificities and their affinities. Immunol Rev 1986;94:99-112
13. 13. Lacroix-Desmazes S, Mouthon L, Coutinho A, Kazatchkine M. Analysis of the natural human IgG antibody repertoire: Lifelong stability of reactivities towards self antigens contrast with age-dependent diversification of reactivities against bacterial antigens. Eur J Immunol 1995;25:2598-2604
14. 14. Avrameas S, Ternyck T. Natural autoantibodies: The other side of the immune system. Res Immunol 1995;146:235-248
15. 15. Wilson G, Miles A. The natural antibodies: Their nature, origin and behaviours: In: Wilson T., ed. Principle of Bacteriology and Immunity. London: Edward Arnold; 1964;1315-1324
16. 16. Boyden S. Natural antibodies and the immune response. Adv Immunol 1966;5:1-28
17. 17. Michael JG. Natural antibodies. Curr Top Immunol Microbiol 1969;48:43-49
18. 18. Kay MM, Goodman SR, Withfield CF, et al. Senescent cell antigen is immunologically related to band 3. Proc Natl Acad Sci USA 1983;80:1631-1635
19. 19. Hintner H, Romani N, Stanzl U, et al. Phagocytosis of keratin filament aggregates following opsonization with IgG-anti-keratin filament autoantibodies. J Invest Dermatol 1987;88: 176-182
20. 20. Lutz HU, Bussolino F, Flepp R, et al. Naturally occurring antiband-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc Natl Acad Sci USA 1987;84:7368-7372
21. 21. Hay FC, Nineham LJ, Torrigiani G, Roitt IM. "Hidden" IgG antiglobulins in normal human serum. Clin Exp Immunol 1976;25:185-190
22. 22. Basta M, Langlois P, Marques M, Frank M, Fries L. High doses intravenous immunoglobulin modifies complement-mediated in vivo clearance. Blood 1989;74:326-333
23. 23. Miletic VD, Hester CG, Frank MM. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin iso-type on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes. J Immunol 1996;156: 749-757
24. 24. Lutz HU, Stammler P, Jelezarova E, Nater M, Spath P. High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes. Blood 1996;88: 184-193
25. 25. Dinarello CA, Thompson RC. Blocking IL-1: Interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991; 12:404-410
26. 26. Ruiz de Souza V, Carreno M, Kaveri S, et al. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin). Eur J Immunol 1995;25:1267-1273
27. 27. Avrameas S. Natural autoantibodies self-recognition and physiological autoimmunity. In: Shoenfeld Y, Isenberg D, eds. Natural Autoantibodies. Boca Raton, FL: CRC Press; 1992:1-14
28. 28. Gilles JG, Saint-Remy J-M. Healthy subjects product both anti-factor VIII and specific anti-idiotypic antibodies. J Clin Invest 1994;94:1496-1505
29. 29. Gilles JG, Desqueper B, Lenk H, Vermylen J, Saint-Remy J-M. Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A. J Clin Invest 1996;97:1382-1388
30. 30. Sultan Y, Kazatchkine M, Maisonneuve P, Nydegger U. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet 1984;2:765-768
31. 31. Sommer N, Melms A, Weller M, Dichgans J. Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects. Doc Ophthalmol 1995;84:309-333
32. 32. Bresler H, Burek C, Hoffman W, Rose N. Autoantigenic determinants on human thyroglobulin: II. Determinants recognized by autoantibodies from patients with chronic autoimmune thyroiditis compared to autoantibodies from healthy subjects. Clin Immunol Immunopathol 1990;54:76-86
33. 33. Peter B, Shoenfeld Y, eds. Autoantibodies. Amsterdam: Elsevier Science; 1996
34. 34. Vanzieleghem B, Gilles JG, Desqueper B, et al. A mouse model for the study of tolerance to factor VIII. Thromb Haemost 1999;(suppl):1296. Abstract
35. 35. Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris) 1974;125C:373-389
36. 36. Buskila D, Shoenfeld Y. Anti-DNA antibodies. Their idiotypes and SLE. Clin Rev Allergy 1994;12:237-252
37. 37. Rossi F, Dietrich G, Kazatchkine MD. Anti-idiotypes against autoantibodies in normal immunoglobulins: Evidence for a network regulation of human autoimmune responses. Immunol Rev 1989;110:135-149
38. 38. Desqueper B, Gilles JG, Jacquemin M, et al. Cohn's fractions as a source of anti-factor VIII and corresponding anti-idiotypic antibodies for possible therapeutic purposes of haemophilia A patients with inhibitors. Thromb Haemost 1995;73(suppl):1011. Abstract
39. 39. Jacquemin MG, Desqueper BG, Benhida A, et al. Mechanisms and kinetics of factor VIII inactivation: Study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor. Blood 1998;92:496-506
40. 40. Nelson EL, Li X, Hsu FJ, et al. Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma. Blood 1996;88:580-589